Molecule of the month. The 'skinny' on CB1 antagonists/inverse agonists: controversial obesity drugs will not go to FDA for approval.

Lindsley Craig W

Vanderbilt University, Vanderbilt University Medical Center, Department of Pharmacology, Nashville, TN 37232-6600, USA.

Curr Top Med Chem. 2008;8(17):1553. doi: 10.2174/156802608786413500.

Abstract

摘要

相似文献

Curr Top Med Chem. 2008;8(17):1553. doi: 10.2174/156802608786413500.

J Med Chem. 2006 Jul 13;49(14):4008-16. doi: 10.1021/jm058238r.

Curr Top Med Chem. 2009;9(6):482-503. doi: 10.2174/156802609788897844.

Int J Cancer. 2008 Apr 15;122(8):1920-1. doi: 10.1002/ijc.23304.

Drug Discov Today. 2010 Jun;15(11-12):411-5. doi: 10.1016/j.drudis.2010.04.004. Epub 2010 May 4.

JAMA. 2012 Sep 19;308(11):1097-8. doi: 10.1001/jama.2012.10007.

Future Med Chem. 2009 Aug;1(5):947-67. doi: 10.4155/fmc.09.64.

J Acad Nutr Diet. 2013 Jan;113(1):25-30. doi: 10.1016/j.jand.2012.08.028.

Obes Rev. 2010 Dec;11(12):833-4. doi: 10.1111/j.1467-789X.2010.00828.x. Epub 2010 Nov 3.

Med Lett Drugs Ther. 2018 Jun 4;60(1548):e98-e100.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。